微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -2.63% | -995.83% | -130.7% | 117/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | -1.14% | -192.31% | -4.59% | 116/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | -1.09% | -419.05% | -153.17% | 98/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 2.05% | 345.65% | 954.17% | 86/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | -0.24% | 61.29% | 38.46% | 100/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | -0.39% | 53.57% | -85.71% | 112/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | -0.21% | 99.06% | -145.65% | 99/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 0.46% | 104.25% | 174.19% | 107/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | -0.62% | 92.34% | 26.19% | 112/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | -0.84% | 71.43% | 96.22% | 117/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | -22.25% | -421.53% | -105.45% | 127/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | -10.83% | -172.64% | -33.87% | 122/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | -8.09% | -157.34% | -175.17% | 126/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | -2.94% | -125.93% | -142.49% | 122/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 6.92% | -73.96% | -53.59% | 83/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 14.91% | -40.93% | 5.67% | 34/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 14.11% | -30.11% | 24.43% | 21/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 11.34% | -15.75% | -57.32% | 14/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 26.57% | 148.09% | 5.27% | 26/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 25.24% | 196.94% | 25.01% | 17/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 20.19% | 199.11% | 50% | 13/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 13.46% | 389.45% | 25.68% | 11/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 10.71% | -33.31% | 26% | 85/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 8.5% | 2% | 25.93% | 59/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 6.75% | 2% | -57.97% | 63/141 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2019-12-31 | 16.06% | -60.7% | 484% | 52/141 | 14.66% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-03-31 | 2.75% | 2% | -93.27% | 22/141 | 2.73% | 健尔康 | 84.09% | 行业排名> |
| 2018-12-31 | 40.87% | 1.89% | 1.89% | 5/141 | 14.23% | 祥生医疗 | 28.56% | 行业排名> |
| 2017-12-31 | 40.11% | 15.16% | 15.16% | 5/141 | 14.51% | 心脉医疗 | 31.04% | 行业排名> |
| 2016-12-31 | 34.83% | 2% | 2% | 11/141 | 16.44% | 新华医疗 | 13.55% | 行业排名> |